Hyaluronidases as Targets for the Treatment of Neurological Diseases.

Saved in:
Bibliographic Details
Title: Hyaluronidases as Targets for the Treatment of Neurological Diseases.
Authors: Sherman LS; Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon, USA., Sorg BA; Program in Neuroscience, Washington State University, Vancouver, Washington, USA.; R.S. Dow Neurobiology, Legacy Research Institute, Portland, Oregon, USA., Matsumoto S; Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.; Department of Biomaterial and Biomedical Science, School of Dentistry, Oregon Health & Science University, Portland, Oregon, USA., Su W; Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Banine F; Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA., Back SA; Department of Neurology, Oregon Health & Science University, Portland, Oregon, USA.; Department of Pediatrics, Oregon Health & Science University, Portland, Oregon, USA.
Source: Proteoglycan research [Proteoglycan Res] 2025 Jul; Vol. 3 (3). Date of Electronic Publication: 2025 Sep 23.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Periodicals LLC Country of Publication: United States NLM ID: 9918589889006676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2832-3556 (Electronic) Linking ISSN: 28323556 NLM ISO Abbreviation: Proteoglycan Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2832-3556
DOI:10.1002/pgr2.70036